MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-06-2026
Mettler-Toledo International ROE Ratio 2011-2026 | MTD
Annual ROE Ratio Mettler-Toledo International
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3677.41 | -680.23 | -526.07 | 3519.15 | 448.59 | 213.23 | 133.35 | 86.87 | 68.7 | 88.37 | 60.78 | 47.0 | 32.74 | 35.16 | 34.5 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3519.15 | -3677.41 | -7.68 |
Quarterly ROE Ratio Mettler-Toledo International
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -392.39 | -442.15 | -509.16 | -394.08 | -584.52 | -637.94 | -731.21 | -1198.99 | -1465.38 | -1541.32 | 1617.42 | 2859.63 | 2961.13 | 3355.49 | 531.74 | 399.85 | 374.86 | 304.12 | 252.37 | 213.23 | 182.52 | 156.04 | 141.49 | 133.35 | 118.25 | 108.96 | 97.63 | 86.87 | 70.23 | 117.47 | 167.27 | 172.48 | 190.1 | 209.77 | 229.44 | 296.79 | 286.37 | 258.78 | 231.19 | 203.6 | 199.19 | 185.41 | 171.63 | 157.85 | 152.79 | 138.53 | 124.26 | 109.99 | 110.86 | 113.28 | 115.7 | 118.13 | 117.55 | 116.89 | 116.23 | 115.57 | 34.5 | 34.5 | 34.5 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3355.49 | -1541.32 | 181.33 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M |  Germany |
 |
CareDx, Inc
CDNA
|
-7.05 | $ 20.61 | -1.67 % | $ 1.1 B |  USA |
 |
Co-Diagnostics
CODX
|
-227.33 | $ 1.6 | 1.9 % | $ 2.13 M | USA |
 |
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | USA |
 |
Castle Biosciences
CSTL
|
4.0 | $ 24.86 | -2.59 % | $ 691 M | USA |
 |
Agilent Technologies
A
|
22.45 | $ 117.2 | 4.6 % | $ 35.6 B | USA |
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Fulgent Genetics
FLGT
|
-3.77 | $ 14.77 | -2.35 % | $ 447 M | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
Illumina
ILMN
|
-51.54 | $ 136.72 | -1.9 % | $ 21.7 B | USA |
 |
Aspira Women's Health
AWH
|
184.36 | - | -6.19 % | $ 10.5 M | USA |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M |  Britain |
 |
Lantheus Holdings
LNTH
|
21.43 | $ 86.64 | -1.3 % | $ 5.85 B | USA |
 |
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M |  Israel |
 |
Medpace Holdings
MEDP
|
98.27 | $ 431.37 | 3.44 % | $ 12.4 B | USA |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
Neogen Corporation
NEOG
|
-52.72 | $ 9.15 | 0.72 % | $ 1.98 B | USA |
 |
National Research Corporation
NRC
|
82.92 | $ 18.81 | 3.24 % | $ 421 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
9.97 | $ 26.38 | 0.53 % | $ 20 B |  Niderland |
 |
ICON Public Limited Company
ICLR
|
8.31 | $ 118.77 | 6.07 % | $ 9.8 B |  Irlanda |
 |
Personalis
PSNL
|
-40.05 | $ 5.76 | -2.37 % | $ 341 M | USA |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
-4.56 | $ 182.94 | 6.15 % | $ 9.07 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
-8.66 | - | - | $ 19.8 B | USA |
 |
Guardant Health
GH
|
419.18 | $ 88.27 | -3.19 % | $ 11.1 B | USA |
 |
Myriad Genetics
MYGN
|
-99.43 | $ 4.89 | -1.11 % | $ 453 M | USA |
 |
Thermo Fisher Scientific
TMO
|
12.55 | $ 465.34 | 0.61 % | $ 175 B | USA |
 |
NeoGenomics
NEO
|
-12.91 | $ 8.84 | -1.83 % | $ 1.13 B | USA |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | Israel |
 |
Twist Bioscience Corporation
TWST
|
-16.42 | $ 56.21 | 0.04 % | $ 3.36 B | USA |
 |
Interpace Biosciences
IDXG
|
109.89 | $ 2.0 | -5.66 % | $ 8.85 M | USA |
 |
Senseonics Holdings
SENS
|
-113.21 | $ 4.86 | -2.99 % | $ 203 M | USA |
 |
Soleno Therapeutics
SLNO
|
4.64 | $ 52.91 | 0.01 % | $ 2.69 B | USA |
 |
QIAGEN N.V.
QGEN
|
11.25 | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
-121.14 | $ 2.2 | 1.85 % | $ 5.05 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 254.79 | 0.71 % | $ 21.2 B | USA |
 |
Celcuity
CELC
|
-176.06 | $ 140.89 | -2.82 % | $ 6.59 B | USA |
 |
Natera
NTRA
|
-77.62 | $ 207.1 | -2.11 % | $ 20.4 B | USA |
 |
Burning Rock Biotech Limited
BNR
|
-43.17 | $ 17.23 | 0.23 % | $ 182 M | China |
 |
Invitae Corporation
NVTA
|
-98.02 | - | - | $ 21.2 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 190.71 | -0.45 % | $ 21.2 B | USA |
 |
OpGen
OPGN
|
162.49 | - | -16.95 % | $ 1.54 M | USA |